|
CA3157525A1
(en)
|
2019-10-25 |
2021-04-29 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
WO2021154796A1
(en)
|
2020-01-29 |
2021-08-05 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
FI4143183T3
(fi)
|
2020-04-29 |
2026-01-07 |
Gasherbrum Bio Inc |
Heterosyklisiä glp-1-agonisteja
|
|
PE20231181A1
(es)
|
2020-08-06 |
2023-08-11 |
Gasherbrum Bio Inc |
Agonistas del glp-1 heterociclicos
|
|
WO2022042691A1
(en)
|
2020-08-28 |
2022-03-03 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
AU2021306414B2
(en)
|
2020-09-01 |
2026-01-29 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
Fused imidazole derivative, preparation method therefor, and medical use thereof
|
|
EP4247804A1
(en)
|
2020-11-20 |
2023-09-27 |
Gilead Sciences, Inc. |
Polyheterocyclic glp-1 r modulating compounds
|
|
CA3209593A1
(en)
*
|
2021-01-28 |
2022-08-04 |
Carmot Therapeutics, Inc. |
Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
|
|
WO2022184849A1
(en)
*
|
2021-03-04 |
2022-09-09 |
Les Laboratoires Servier |
Glp-1r agonists, uses and pharmaceutical compositions thereof
|
|
WO2022192430A1
(en)
*
|
2021-03-11 |
2022-09-15 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
EP4304711A1
(en)
*
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
CN116940561A
(zh)
*
|
2021-03-22 |
2023-10-24 |
杭州中美华东制药有限公司 |
噻吩类glp-1受体激动剂及其用途
|
|
WO2022202864A1
(ja)
|
2021-03-24 |
2022-09-29 |
塩野義製薬株式会社 |
縮合環を有するｇｌｐ－１受容体作動薬を含有する医薬組成物
|
|
WO2022199661A1
(en)
*
|
2021-03-24 |
2022-09-29 |
Eccogene (Shanghai) Co., Ltd. |
Phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-phenyl-, phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-heteroaryl-, or phenyl- [1, 3] dioxolo [4, 5-c] pyridinyl-piperidinyl-methyl-oxetanylmethyl-1h-benzo [d] imidazole-carboxylic acid derivatives and methods of using same
|
|
PH12023552860A1
(en)
|
2021-04-21 |
2024-05-20 |
Gilead Sciences Inc |
Carboxy-benzimidazole glp-1r modulating compounds
|
|
TWI843104B
(zh)
|
2021-05-20 |
2024-05-21 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
EP4382525A4
(en)
*
|
2021-08-04 |
2025-07-16 |
Shanghai Hansoh Biomedical Co Ltd |
CYCLOALKENE DERIVATIVE REGULATOR, PREPARATION METHOD AND USE THEREOF
|
|
WO2023038039A1
(ja)
|
2021-09-08 |
2023-03-16 |
塩野義製薬株式会社 |
抗肥満作用の関与する疾患の予防及び治療用医薬
|
|
KR20240068737A
(ko)
|
2021-09-27 |
2024-05-17 |
테른스 파마슈티칼스, 인크. |
Glp-1r 효능제로서의 벤즈이미다졸 카복실산
|
|
WO2023057414A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
AU2022358915A1
(en)
|
2021-10-05 |
2024-05-09 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulators
|
|
WO2023057429A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
AU2022375634A1
(en)
|
2021-10-25 |
2024-06-06 |
Terns Pharmaceuticals, Inc. |
Compounds as glp-1r agonists
|
|
US20250066338A1
(en)
|
2021-12-16 |
2025-02-27 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
WO2023111145A1
(en)
|
2021-12-16 |
2023-06-22 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
KR20240150488A
(ko)
|
2022-02-23 |
2024-10-15 |
테른스 파마슈티칼스, 인크. |
Glp-1r 작용제로서의 화합물
|
|
WO2023182869A1
(en)
*
|
2022-03-25 |
2023-09-28 |
Ildong Pharmaceutical Co., Ltd. |
Novel salt of glp-1 receptor agonist compound, preparation method thereof and pharmaceutical composition comprising thereof
|
|
US20250136584A1
(en)
*
|
2022-05-20 |
2025-05-01 |
Chengdu Di'ao Jiuhong Pharmaceutical Factory |
Benzimidazole Or Azabenzimidazole Compound, Preparation Method Therefor And Use Thereof
|
|
CN117003744B
(zh)
*
|
2022-07-18 |
2025-08-15 |
厦门市博瑞来医药科技有限公司 |
五元并六元化合物、其中间体、制备方法、组合物和应用
|
|
US20260097037A1
(en)
|
2022-09-22 |
2026-04-09 |
Shionogi & Co., Ltd. |
Fused ring compound having glp-1 receptor agonist effect
|
|
JPWO2024063140A1
(https=)
*
|
2022-09-22 |
2024-03-28 |
|
|
|
CN116102543B
(zh)
*
|
2022-10-21 |
2025-07-22 |
江南大学 |
一种glp-1r激动剂、合成方法及其用途
|
|
WO2024102625A1
(en)
|
2022-11-11 |
2024-05-16 |
Eli Lilly And Company |
Glucagon-like peptide 1 receptor agonists
|
|
IL320810A
(en)
|
2022-11-16 |
2025-07-01 |
Lilly Co Eli |
Glucagon-like peptide 1 receptor agonists
|
|
EP4660194A1
(en)
*
|
2023-02-02 |
2025-12-10 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Salt and crystal form of cycloalkene compound, and preparation method therefor and use thereof
|
|
US20240398794A1
(en)
|
2023-04-07 |
2024-12-05 |
Terns Pharmaceuticals, Inc. |
COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF
|
|
WO2024212742A1
(zh)
*
|
2023-04-10 |
2024-10-17 |
上海研健新药研发有限公司 |
一种glp-1r激动剂，其制备方法和应用
|
|
TW202521533A
(zh)
|
2023-09-14 |
2025-06-01 |
香港商歌禮製藥(中國)有限公司 |
Glp-1r 激動劑及其治療方法
|
|
CN121889388A
(zh)
*
|
2023-09-21 |
2026-04-17 |
尹诺卫医药有限公司 |
制备取代的稠合咪唑衍生物的方法
|
|
US12291530B1
(en)
|
2023-11-24 |
2025-05-06 |
Ascletis Pharma (China) Co., Limited |
GLP-1R agonist and therapeutic method thereof
|
|
WO2025189141A1
(en)
|
2024-03-08 |
2025-09-12 |
Annapurna Bio, Inc. |
Methods for treating obesity and increasing weight loss
|